Protective effect of metformin against walker 256 tumor growth is not dependent on metabolism improvement.
| Autor: | Franco CC; Laboratory of Secretion Cell Biology, Department of Biotecnology, Genetics and Cell Biology, State University of Maringá, Maringá/PR, Brazil., Miranda RA, de Oliveira JC, Barella LF, Agostinho AR, Prates KV, Malta A, Trombini AB, Torrezan R, Gravena C, Tófolo LP, de Sant'Anna JR, de Castro Prado MA, de Souza CO, de Souza HM, Beraldi EJ, Mathias PC |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology [Cell Physiol Biochem] 2014; Vol. 34 (6), pp. 1920-32. Date of Electronic Publication: 2014 Nov 21. |
| DOI: | 10.1159/000366390 |
| Abstrakt: | Background/aims: The objective of the current work was to test the effect of metformin on the tumor growth in rats with metabolic syndrome. Methods: We obtained pre-diabetic hyperinsulinemic rats by neonatal treatment with monosodium L-glutamate (MSG), which were chronically treated every day, from weaning to 100 day old, with dose of metformin (250 mg/kg body weight). After the end of metformin treatment, the control and MSG rats, treated or untreated with metformin, were grafted with Walker 256 carcinoma cells. Tumor weight was evaluated 14 days after cancer cell inoculation. The blood insulin, glucose levels and glucose-induced insulin secretion were evaluated. Results: Chronic metformin treatment improved the glycemic homeostasis in pre-diabetic MSG-rats, glucose intolerance, tissue insulin resistance, hyperinsulinemia and decreased the fat tissue accretion. Meanwhile, the metformin treatment did not interfere with the glucose insulinotropic effect on isolated pancreatic islets. Chronic treatment with metformin was able to decrease the Walker 256 tumor weight by 37% in control and MSG rats. The data demonstrated that the anticancer effect of metformin is not related to its role in correcting metabolism imbalances, such as hyperinsulinemia. However, in morphological assay to apoptosis, metformin treatment increased programmed cell death. Conclusion: Metformin may have a direct effect on cancer growth, and it may programs the rat organism to attenuate the growth of Walker 256 carcinoma. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|